Regulation of M₂, M₃, and M₄ muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol

References

• Bonner TI, Buckley NJ, Young AC, Brann MR. Identification of a family of muscarinic acetylcholine receptor genes. Science 1987, 237, 527–532.
   PubMed Web of Science ®Google Scholar
• Bonner TI, Young AC, Brann MR, Buckley NJ. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1988, 1, 403–410.
   PubMedGoogle Scholar
• Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 1987, 6, 3923–3929.
   PubMed Web of Science ®Google Scholar
• Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 1995, 9, 619–625.
   PubMed Web of Science ®Google Scholar
• Caulfield MP. Muscarinic receptors–characterization, coupling and function. Pharmacol Ther 1993, 58, 319–379.
   PubMed Web of Science ®Google Scholar
• Hulme EC, Birdsall NJ, Buckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990, 30, 633–673.
   PubMed Web of Science ®Google Scholar
• Eglen RM, Choppin A, Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 2001, 22, 409–414.
   PubMed Web of Science ®Google Scholar
• Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998, 50, 279–290.
   PubMed Web of Science ®Google Scholar
• Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci 2003, 72, 2055–2061.
   PubMed Web of Science ®Google Scholar
• Peretto I, Petrillo P, Imbimbo BP. Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists. Med Res Rev 2009, 29, 867–902.
   PubMed Web of Science ®Google Scholar
• Stope MB, Kunkel C, Kories C, Schmidt M, Michel MC. Differential agonist-induced regulation of human M2 and M3 muscarinic receptors. Biochem Pharmacol 2003, 66, 2099–2105.
   Google Scholar
• McKinney M, Coyle JT. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer’s disease. Mayo Clin Proc 1991, 66, 1225–1237.
   Google Scholar
• Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH. Alzheimer-like cholinergic deficiency in Down syndrome. Lancet 1980, 2, 979.
   PubMed Web of Science ®Google Scholar
• Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y. A subcortico-cortical cholinergic system is affected in Parkinson’s disease. Brain Res 1983, 288, 213–218.
   PubMed Web of Science ®Google Scholar
• Steel MC, Buckley NJ. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study. Mol Pharmacol 1993, 43, 694–701.
   Google Scholar
• Fukamauchi F, Saunders PA, Hough C, Chuang DM. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol Pharmacol 1993, 44, 940–949.
   PubMed Web of Science ®Google Scholar
• Longone P, Mocchetti I, Riva MA, Wojcik WJ. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol. J Pharmacol Exp Ther 1993, 265, 441–446.
   Google Scholar
• Haddad EB, Rousell J, Mak JC, Barnes PJ. Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line. Br J Pharmacol 1995, 116, 2027–2032.
   Google Scholar
• Habecker BA, Nathanson NM. Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors. Proc Natl Acad Sci USA 1992, 89, 5035–5038.
   PubMed Web of Science ®Google Scholar
• Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 2000, 86, 29–48.
   PubMed Web of Science ®Google Scholar
• Maslinski W. Cholinergic receptors of lymphocytes. Brain Behav Immun 1989, 3, 1–14.
   PubMedGoogle Scholar
• Kaneda T, Kitamura Y, Nomura Y. Presence of M3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line. Mol Pharmacol 1993, 43, 356–364.
   Google Scholar
• Sato KZ, Fujii T, Watanabe Y, Yamada S, Ando T, Kazuko F, Kawashima K. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 1999, 266, 17–20.
   PubMed Web of Science ®Google Scholar
• Tayebati SK, Codini M, Gallai V, Mannino F, Parnetti L, Ricci A, Sarchielli P, Amenta F. Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 1999, 99, 224–229.
   PubMed Web of Science ®Google Scholar
• Cabadak H, Küçükibrahimoglu E, Aydin B, Kan B, Zafer Gören M. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line. Auton Autacoid Pharmacol 2009, 29, 109–115.
   PubMedGoogle Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162, 156–159.
   PubMed Web of Science ®Google Scholar
• Wang J, Krysiak PS, Laurier LG, Sims SM, Preiksaitis HG. Human esophageal smooth muscle cells express muscarinic receptor subtypes M1 through M5. Am J Physiol Gastrointest Liver Physiol 2000, 279, G1059–G1069.
   Web of Science ®Google Scholar
• Rodenburg RJ, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF alpha, IL-1beta, and IL-8 mRNA levels. A comparison of monocyte isolation procedures. J Immunol Methods 1998, 221, 169–175.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991, 11, 3218–3226.
   PubMed Web of Science ®Google Scholar
• Costa P, Traver DJ, Auger CB, Costa LG. Expression of cholinergic muscarinic receptor subtypes mRNA in rat blood mononuclear cells. Immunopharmacology 1994, 28, 113–123.
   Google Scholar
• Lefkowitz RJ, Stadel JM, Caron MG. Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu Rev Biochem 1983, 52, 159–186.
   PubMed Web of Science ®Google Scholar
• Wang S-Z Hu, J, Long R, Pou WS, Forray C, El-Fakahany, EE. Agonist-induced downregulation of M1 muscarinic receptors and reduction of their mRNA level in a transfected cell line. FEBS Lett 1990, 276, 185–188.
   Google Scholar
• Ashkenazi A, Ramachandran J, Capon DJ. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature 1989, 340, 146–150.
   PubMedGoogle Scholar
• Williams CL, Lennon VA. Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. Cell Regul 1991, 2, 373–381.
   PubMedGoogle Scholar
• Nicke B, Detjen K, Logsdon CD. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem 1999, 274, 21701–21706.
   PubMed Web of Science ®Google Scholar
• Costa LG, Guizzetti M, Oberdoerster J, Yagle K, Costa-Mallen P, Tita B, Bordi F, Vitalone A, Palmery M, Valeri P. Modulation of DNA synthesis by muscarinic cholinergic receptors. Growth Factors 2001, 18, 227–236.
   PubMed Web of Science ®Google Scholar
• Brown JH, Sah V, Moskowitz S, Ramirez T, Collins L, Post G, Goldstein D. Pathways and roadblocks in muscarinic receptor-mediated growth regulation. Life Sci 1997, 60, 1077–1084.
   PubMedGoogle Scholar
• Resende RR, Adhikari A. Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun Signal 2009, 7, 20.
   PubMed Web of Science ®Google Scholar
• Williams CL. Muscarinic signaling in carcinoma cells. Life Sci 2003, 72, 2173–2182.
   Google Scholar
• Paleari L, Grozio A, Cesario A, Russo P. The cholinergic system and cancer. Semin Cancer Biol 2008, 18, 211–217.
   PubMed Web of Science ®Google Scholar
• Burdon D, Patel R, Challiss RA, Blank JL. Growth inhibition by the muscarinic M3 acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G1 arrest. Biochem J 2002, 367, 549–559.
   Google Scholar